生物製剤開発製造受託機関（CDMO）の世界市場 2024-2028

概要

生物製剤開発製造受託機関（CDMO）市場は2023-2028年に106億3,000万米ドル、予測期間中のCAGRは10.46%で成長すると予測されます。

当レポートでは、生物製剤開発製造受託機関（CDMO）市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。新興国市場におけるコスト効率の高いリソースの利用可能性、生物製剤治療薬の強力な研究開発パイプライン、コアコンピタンスに集中する必要性の高まりなどが市場を牽引しています。

本調査では、ビッグデータの出現が今後数年間の生物製剤開発製造受託機関（CDMO）市場成長を牽引する主要因の1つであるとしています。また、CDMOベンダーと製薬企業との戦略的提携やパートナーシップ、新分子やバイオシミラーの承認増加も、市場の大きな需要につながると思われます。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場エコシステム

第3章 市場規模

• 市場の定義
• 市場セグメント分析
• 市場規模 2023
• 市場の見通し 2023-2028

第4章 市場規模実績

• 生物製剤開発製造受託機関（CDMO）の世界市場 2018-2022
• タイプ別セグメント分析 2018-2022
• 製品タイプ別セグメント分析 2018-2022
• 地域別セグメント分析 2018-2022
• 国別セグメント分析 2018-2022

第5章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第6章 市場セグメンテーション：タイプ別

• 市場セグメント
• 比較：タイプ別
• 哺乳類：市場規模と予測 2023-2028
• 微生物：市場規模と予測 2023-2028
• 市場機会：タイプ別

第7章 市場セグメンテーション：製品タイプ別

• 市場セグメント
• 比較：製品タイプ別
• 生物製剤：市場規模と予測 2023-2028
• バイオシミラー：市場規模と予測 2023-2028
• 市場機会：製品タイプ別

第8章 顧客情勢

• 顧客情勢の概要

第9章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米：市場規模と予測 2023-2028
• 欧州：市場規模と予測 2023-2028
• アジア：市場規模と予測 2023-2028
• 世界のその他の地域：市場規模と予測 2023-2028
• 米国：市場規模と予測 2023-2028
• ドイツ：市場規模と予測 2023-2028
• 中国：市場規模と予測 2023-2028
• フランス：市場規模と予測 2023-2028
• 日本：市場規模と予測 2023-2028
• 市場機会：地域情勢別

第10章 促進要因、課題、および動向

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場動向

第11章 ベンダー情勢

• 概要
• ベンダー情勢
• 混乱の状況
• 業界のリスク

第12章 ベンダー分析

• 対象ベンダー
• ベンダーの市場ポジショニング
• AbbVie Inc.
• Binex Co. Ltd.
• Boehringer Ingelheim International GmbH
• Bora Pharmaceuticals Co. Ltd
• Catalent Inc.
• Evonik Industries AG
• FUJIFILM Corp.
• Grifols SA
• J RETTENMAIER and SOHNE GmbH and Co KG
• Lonza Group Ltd.
• Novartis AG
• Rentschler Biopharma SE
• Samsung Electronics Co. Ltd.
• Toyobo Co. Ltd.
• WuXi Biologics Cayman Inc.

第13章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Type
• Exhibits6: Executive Summary - Chart on Market Segmentation by Product Type
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits18: Historic Market Size - Data Table on global biologics contract development and manufacturing organization (cdmo) market 2018 - 2022 ($ billion)
• Exhibits19: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
• Exhibits20: Historic Market Size - Product Type Segment 2018 - 2022 ($ billion)
• Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
• Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
• Exhibits23: Five forces analysis - Comparison between 2023 and 2028
• Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
• Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
• Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
• Exhibits29: Chart on Market condition - Five forces 2023 and 2028
• Exhibits30: Chart on Type - Market share 2023-2028 (%)
• Exhibits31: Data Table on Type - Market share 2023-2028 (%)
• Exhibits32: Chart on Comparison by Type
• Exhibits33: Data Table on Comparison by Type
• Exhibits34: Chart on Mammalian - Market size and forecast 2023-2028 ($ billion)
• Exhibits35: Data Table on Mammalian - Market size and forecast 2023-2028 ($ billion)
• Exhibits36: Chart on Mammalian - Year-over-year growth 2023-2028 (%)
• Exhibits37: Data Table on Mammalian - Year-over-year growth 2023-2028 (%)
• Exhibits38: Chart on Microbial - Market size and forecast 2023-2028 ($ billion)
• Exhibits39: Data Table on Microbial - Market size and forecast 2023-2028 ($ billion)
• Exhibits40: Chart on Microbial - Year-over-year growth 2023-2028 (%)
• Exhibits41: Data Table on Microbial - Year-over-year growth 2023-2028 (%)
• Exhibits42: Market opportunity by Type ($ billion)
• Exhibits43: Data Table on Market opportunity by Type ($ billion)
• Exhibits44: Chart on Product Type - Market share 2023-2028 (%)
• Exhibits45: Data Table on Product Type - Market share 2023-2028 (%)
• Exhibits46: Chart on Comparison by Product Type
• Exhibits47: Data Table on Comparison by Product Type
• Exhibits48: Chart on Biologics - Market size and forecast 2023-2028 ($ billion)
• Exhibits49: Data Table on Biologics - Market size and forecast 2023-2028 ($ billion)
• Exhibits50: Chart on Biologics - Year-over-year growth 2023-2028 (%)
• Exhibits51: Data Table on Biologics - Year-over-year growth 2023-2028 (%)
• Exhibits52: Chart on Biosimilars - Market size and forecast 2023-2028 ($ billion)
• Exhibits53: Data Table on Biosimilars - Market size and forecast 2023-2028 ($ billion)
• Exhibits54: Chart on Biosimilars - Year-over-year growth 2023-2028 (%)
• Exhibits55: Data Table on Biosimilars - Year-over-year growth 2023-2028 (%)
• Exhibits56: Market opportunity by Product Type ($ billion)
• Exhibits57: Data Table on Market opportunity by Product Type ($ billion)
• Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits59: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits61: Chart on Geographic comparison
• Exhibits62: Data Table on Geographic comparison
• Exhibits63: Chart on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibits64: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibits65: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibits66: Data Table on North America - Year-over-year growth 2023-2028 (%)
• Exhibits67: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibits68: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibits69: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits71: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibits72: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibits73: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibits76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibits77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits79: Chart on US - Market size and forecast 2023-2028 ($ billion)
• Exhibits80: Data Table on US - Market size and forecast 2023-2028 ($ billion)
• Exhibits81: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibits82: Data Table on US - Year-over-year growth 2023-2028 (%)
• Exhibits83: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibits84: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibits85: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits86: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits87: Chart on China - Market size and forecast 2023-2028 ($ billion)
• Exhibits88: Data Table on China - Market size and forecast 2023-2028 ($ billion)
• Exhibits89: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibits90: Data Table on China - Year-over-year growth 2023-2028 (%)
• Exhibits91: Chart on France - Market size and forecast 2023-2028 ($ billion)
• Exhibits92: Data Table on France - Market size and forecast 2023-2028 ($ billion)
• Exhibits93: Chart on France - Year-over-year growth 2023-2028 (%)
• Exhibits94: Data Table on France - Year-over-year growth 2023-2028 (%)
• Exhibits95: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
• Exhibits96: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
• Exhibits97: Chart on Japan - Year-over-year growth 2023-2028 (%)
• Exhibits98: Data Table on Japan - Year-over-year growth 2023-2028 (%)
• Exhibits99: Market opportunity By Geographical Landscape ($ billion)
• Exhibits100: Data Tables on Market opportunity By Geographical Landscape ($ billion)
• Exhibits101: Impact of drivers and challenges in 2023 and 2028
• Exhibits102: Overview on Criticality of inputs and Factors of differentiation
• Exhibits103: Overview on factors of disruption
• Exhibits104: Impact of key risks on business
• Exhibits105: Vendors covered
• Exhibits106: Matrix on vendor position and classification
• Exhibits107: AbbVie Inc. - Overview
• Exhibits108: AbbVie Inc. - Product / Service
• Exhibits109: AbbVie Inc. - Key news
• Exhibits110: AbbVie Inc. - Key offerings
• Exhibits111: Binex Co. Ltd. - Overview
• Exhibits112: Binex Co. Ltd. - Product / Service
• Exhibits113: Binex Co. Ltd. - Key offerings
• Exhibits114: Boehringer Ingelheim International GmbH - Overview
• Exhibits115: Boehringer Ingelheim International GmbH - Business segments
• Exhibits116: Boehringer Ingelheim International GmbH - Key news
• Exhibits117: Boehringer Ingelheim International GmbH - Key offerings
• Exhibits118: Boehringer Ingelheim International GmbH - Segment focus
• Exhibits119: Bora Pharmaceuticals Co. Ltd - Overview
• Exhibits120: Bora Pharmaceuticals Co. Ltd - Product / Service
• Exhibits121: Bora Pharmaceuticals Co. Ltd - Key offerings
• Exhibits122: Catalent Inc. - Overview
• Exhibits123: Catalent Inc. - Business segments
• Exhibits124: Catalent Inc. - Key news
• Exhibits125: Catalent Inc. - Key offerings
• Exhibits126: Catalent Inc. - Segment focus
• Exhibits127: Evonik Industries AG - Overview
• Exhibits128: Evonik Industries AG - Business segments
• Exhibits129: Evonik Industries AG - Key news
• Exhibits130: Evonik Industries AG - Key offerings
• Exhibits131: Evonik Industries AG - Segment focus
• Exhibits132: FUJIFILM Corp. - Overview
• Exhibits133: FUJIFILM Corp. - Business segments
• Exhibits134: FUJIFILM Corp. - Key offerings
• Exhibits135: FUJIFILM Corp. - Segment focus
• Exhibits136: Grifols SA - Overview
• Exhibits137: Grifols SA - Business segments
• Exhibits138: Grifols SA - Key offerings
• Exhibits139: Grifols SA - Segment focus
• Exhibits140: J RETTENMAIER and SOHNE GmbH and Co KG - Overview
• Exhibits141: J RETTENMAIER and SOHNE GmbH and Co KG - Product / Service
• Exhibits142: J RETTENMAIER and SOHNE GmbH and Co KG - Key offerings
• Exhibits143: Lonza Group Ltd. - Overview
• Exhibits144: Lonza Group Ltd. - Business segments
• Exhibits145: Lonza Group Ltd. - Key news
• Exhibits146: Lonza Group Ltd. - Key offerings
• Exhibits147: Lonza Group Ltd. - Segment focus
• Exhibits148: Novartis AG - Overview
• Exhibits149: Novartis AG - Business segments
• Exhibits150: Novartis AG - Key offerings
• Exhibits151: Novartis AG - Segment focus
• Exhibits152: Rentschler Biopharma SE - Overview
• Exhibits153: Rentschler Biopharma SE - Product / Service
• Exhibits154: Rentschler Biopharma SE - Key offerings
• Exhibits155: Samsung Electronics Co. Ltd. - Overview
• Exhibits156: Samsung Electronics Co. Ltd. - Business segments
• Exhibits157: Samsung Electronics Co. Ltd. - Key news
• Exhibits158: Samsung Electronics Co. Ltd. - Key offerings
• Exhibits159: Samsung Electronics Co. Ltd. - Segment focus
• Exhibits160: Toyobo Co. Ltd. - Overview
• Exhibits161: Toyobo Co. Ltd. - Business segments
• Exhibits162: Toyobo Co. Ltd. - Key offerings
• Exhibits163: Toyobo Co. Ltd. - Segment focus
• Exhibits164: WuXi Biologics Cayman Inc. - Overview
• Exhibits165: WuXi Biologics Cayman Inc. - Product / Service
• Exhibits166: WuXi Biologics Cayman Inc. - Key offerings
• Exhibits167: Inclusions checklist
• Exhibits168: Exclusions checklist
• Exhibits169: Currency conversion rates for US$
• Exhibits170: Research methodology
• Exhibits171: Validation techniques employed for market sizing
• Exhibits172: Information sources
• Exhibits173: List of abbreviations

Abstract

The biologics contract development and manufacturing organization (CDMO) market is forecasted to grow by USD 10.63 bn during 2023-2028, accelerating at a CAGR of 10.46% during the forecast period. The report on the biologics contract development and manufacturing organization (CDMO) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by availability of cost-efficient resources in emerging markets, strong research and development pipeline of biologics therapeutics, and growing need to focus on core competencies.

Technavio's biologics contract development and manufacturing organization (CDMO) market is segmented as below:

By Type

• Mammalian
• Microbial

By Product Type

• Biologics
• Biosimilars

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the advent of big data as one of the prime reasons driving the biologics contract development and manufacturing organization (CDMO) market growth during the next few years. Also, strategic alliances and partnerships of CDMO vendors with pharma companies and increasing approvals for new molecules and biosimilars will lead to sizable demand in the market.

The report on the biologics contract development and manufacturing organization (CDMO) market covers the following areas:

• Biologics contract development and manufacturing organization (CDMO) market sizing
• Biologics contract development and manufacturing organization (CDMO) market forecast
• Biologics contract development and manufacturing organization (CDMO) market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading biologics contract development and manufacturing organization (CDMO) market vendors that include 3P BIOPHARMACEUTICALS S.L.U, AbbVie Inc., AGC Biologics, Binex Co. Ltd., Boehringer Ingelheim International GmbH, Bora Pharmaceuticals Co. Ltd, Catalent Inc., Evonik Industries AG, FUJIFILM Corp., Grifols SA, J RETTENMAIER and SOHNE GmbH and Co KG, JSR Corp., Kemwell Biopharma Pvt. Ltd., Lonza Group Ltd., Novartis AG, Rentschler Biopharma SE, Samsung Electronics Co. Ltd., Shenzhen Hepalink Pharmaceutical Co. Ltd., Toyobo Co. Ltd., and WuXi Biologics Cayman Inc.. Also, the biologics contract development and manufacturing organization (CDMO) market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Product Type
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
• Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global biologics contract development and manufacturing organization (CDMO) market 2018 - 2022
• Exhibit 18: Historic Market Size - Data Table on global biologics contract development and manufacturing organization (cdmo) market 2018 - 2022 ($ billion)
• 4.2 Type Segment Analysis 2018 - 2022
• Exhibit 19: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
• 4.3 Product Type Segment Analysis 2018 - 2022
• Exhibit 20: Historic Market Size - Product Type Segment 2018 - 2022 ($ billion)
• 4.4 Geography Segment Analysis 2018 - 2022
• Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
• 4.5 Country Segment Analysis 2018 - 2022
• Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Type

• 6.1 Market segments
• Exhibit 30: Chart on Type - Market share 2023-2028 (%)
• Exhibit 31: Data Table on Type - Market share 2023-2028 (%)
• 6.2 Comparison by Type
• Exhibit 32: Chart on Comparison by Type
• Exhibit 33: Data Table on Comparison by Type
• 6.3 Mammalian - Market size and forecast 2023-2028
• Exhibit 34: Chart on Mammalian - Market size and forecast 2023-2028 ($ billion)
• Exhibit 35: Data Table on Mammalian - Market size and forecast 2023-2028 ($ billion)
• Exhibit 36: Chart on Mammalian - Year-over-year growth 2023-2028 (%)
• Exhibit 37: Data Table on Mammalian - Year-over-year growth 2023-2028 (%)
• 6.4 Microbial - Market size and forecast 2023-2028
• Exhibit 38: Chart on Microbial - Market size and forecast 2023-2028 ($ billion)
• Exhibit 39: Data Table on Microbial - Market size and forecast 2023-2028 ($ billion)
• Exhibit 40: Chart on Microbial - Year-over-year growth 2023-2028 (%)
• Exhibit 41: Data Table on Microbial - Year-over-year growth 2023-2028 (%)
• 6.5 Market opportunity by Type
• Exhibit 42: Market opportunity by Type ($ billion)
• Exhibit 43: Data Table on Market opportunity by Type ($ billion)

7 Market Segmentation by Product Type

• 7.1 Market segments
• Exhibit 44: Chart on Product Type - Market share 2023-2028 (%)
• Exhibit 45: Data Table on Product Type - Market share 2023-2028 (%)
• 7.2 Comparison by Product Type
• Exhibit 46: Chart on Comparison by Product Type
• Exhibit 47: Data Table on Comparison by Product Type
• 7.3 Biologics - Market size and forecast 2023-2028
• Exhibit 48: Chart on Biologics - Market size and forecast 2023-2028 ($ billion)
• Exhibit 49: Data Table on Biologics - Market size and forecast 2023-2028 ($ billion)
• Exhibit 50: Chart on Biologics - Year-over-year growth 2023-2028 (%)
• Exhibit 51: Data Table on Biologics - Year-over-year growth 2023-2028 (%)
• 7.4 Biosimilars - Market size and forecast 2023-2028
• Exhibit 52: Chart on Biosimilars - Market size and forecast 2023-2028 ($ billion)
• Exhibit 53: Data Table on Biosimilars - Market size and forecast 2023-2028 ($ billion)
• Exhibit 54: Chart on Biosimilars - Year-over-year growth 2023-2028 (%)
• Exhibit 55: Data Table on Biosimilars - Year-over-year growth 2023-2028 (%)
• 7.5 Market opportunity by Product Type
• Exhibit 56: Market opportunity by Product Type ($ billion)
• Exhibit 57: Data Table on Market opportunity by Product Type ($ billion)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 59: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibit 60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 9.2 Geographic comparison
• Exhibit 61: Chart on Geographic comparison
• Exhibit 62: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
• Exhibit 63: Chart on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibit 64: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibit 65: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibit 66: Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.4 Europe - Market size and forecast 2023-2028
• Exhibit 67: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibit 68: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibit 69: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibit 70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.5 Asia - Market size and forecast 2023-2028
• Exhibit 71: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibit 72: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibit 73: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibit 74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
• Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 9.7 US - Market size and forecast 2023-2028
• Exhibit 79: Chart on US - Market size and forecast 2023-2028 ($ billion)
• Exhibit 80: Data Table on US - Market size and forecast 2023-2028 ($ billion)
• Exhibit 81: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibit 82: Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.8 Germany - Market size and forecast 2023-2028
• Exhibit 83: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibit 84: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibit 85: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibit 86: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 9.9 China - Market size and forecast 2023-2028
• Exhibit 87: Chart on China - Market size and forecast 2023-2028 ($ billion)
• Exhibit 88: Data Table on China - Market size and forecast 2023-2028 ($ billion)
• Exhibit 89: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibit 90: Data Table on China - Year-over-year growth 2023-2028 (%)
• 9.10 France - Market size and forecast 2023-2028
• Exhibit 91: Chart on France - Market size and forecast 2023-2028 ($ billion)
• Exhibit 92: Data Table on France - Market size and forecast 2023-2028 ($ billion)
• Exhibit 93: Chart on France - Year-over-year growth 2023-2028 (%)
• Exhibit 94: Data Table on France - Year-over-year growth 2023-2028 (%)
• 9.11 Japan - Market size and forecast 2023-2028
• Exhibit 95: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
• Exhibit 96: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
• Exhibit 97: Chart on Japan - Year-over-year growth 2023-2028 (%)
• Exhibit 98: Data Table on Japan - Year-over-year growth 2023-2028 (%)
• 9.12 Market opportunity By Geographical Landscape
• Exhibit 99: Market opportunity By Geographical Landscape ($ billion)
• Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 101: Impact of drivers and challenges in 2023 and 2028
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 103: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 104: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 105: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 106: Matrix on vendor position and classification
• 12.3 AbbVie Inc.
• Exhibit 107: AbbVie Inc. - Overview
• Exhibit 108: AbbVie Inc. - Product / Service
• Exhibit 109: AbbVie Inc. - Key news
• Exhibit 110: AbbVie Inc. - Key offerings
• 12.4 Binex Co. Ltd.
• Exhibit 111: Binex Co. Ltd. - Overview
• Exhibit 112: Binex Co. Ltd. - Product / Service
• Exhibit 113: Binex Co. Ltd. - Key offerings
• 12.5 Boehringer Ingelheim International GmbH
• Exhibit 114: Boehringer Ingelheim International GmbH - Overview
• Exhibit 115: Boehringer Ingelheim International GmbH - Business segments
• Exhibit 116: Boehringer Ingelheim International GmbH - Key news
• Exhibit 117: Boehringer Ingelheim International GmbH - Key offerings
• Exhibit 118: Boehringer Ingelheim International GmbH - Segment focus
• 12.6 Bora Pharmaceuticals Co. Ltd
• Exhibit 119: Bora Pharmaceuticals Co. Ltd - Overview
• Exhibit 120: Bora Pharmaceuticals Co. Ltd - Product / Service
• Exhibit 121: Bora Pharmaceuticals Co. Ltd - Key offerings
• 12.7 Catalent Inc.
• Exhibit 122: Catalent Inc. - Overview
• Exhibit 123: Catalent Inc. - Business segments
• Exhibit 124: Catalent Inc. - Key news
• Exhibit 125: Catalent Inc. - Key offerings
• Exhibit 126: Catalent Inc. - Segment focus
• 12.8 Evonik Industries AG
• Exhibit 127: Evonik Industries AG - Overview
• Exhibit 128: Evonik Industries AG - Business segments
• Exhibit 129: Evonik Industries AG - Key news
• Exhibit 130: Evonik Industries AG - Key offerings
• Exhibit 131: Evonik Industries AG - Segment focus
• 12.9 FUJIFILM Corp.
• Exhibit 132: FUJIFILM Corp. - Overview
• Exhibit 133: FUJIFILM Corp. - Business segments
• Exhibit 134: FUJIFILM Corp. - Key offerings
• Exhibit 135: FUJIFILM Corp. - Segment focus
• 12.10 Grifols SA
• Exhibit 136: Grifols SA - Overview
• Exhibit 137: Grifols SA - Business segments
• Exhibit 138: Grifols SA - Key offerings
• Exhibit 139: Grifols SA - Segment focus
• 12.11 J RETTENMAIER and SOHNE GmbH and Co KG
• Exhibit 140: J RETTENMAIER and SOHNE GmbH and Co KG - Overview
• Exhibit 141: J RETTENMAIER and SOHNE GmbH and Co KG - Product / Service
• Exhibit 142: J RETTENMAIER and SOHNE GmbH and Co KG - Key offerings
• 12.12 Lonza Group Ltd.
• Exhibit 143: Lonza Group Ltd. - Overview
• Exhibit 144: Lonza Group Ltd. - Business segments
• Exhibit 145: Lonza Group Ltd. - Key news
• Exhibit 146: Lonza Group Ltd. - Key offerings
• Exhibit 147: Lonza Group Ltd. - Segment focus
• 12.13 Novartis AG
• Exhibit 148: Novartis AG - Overview
• Exhibit 149: Novartis AG - Business segments
• Exhibit 150: Novartis AG - Key offerings
• Exhibit 151: Novartis AG - Segment focus
• 12.14 Rentschler Biopharma SE
• Exhibit 152: Rentschler Biopharma SE - Overview
• Exhibit 153: Rentschler Biopharma SE - Product / Service
• Exhibit 154: Rentschler Biopharma SE - Key offerings
• 12.15 Samsung Electronics Co. Ltd.
• Exhibit 155: Samsung Electronics Co. Ltd. - Overview
• Exhibit 156: Samsung Electronics Co. Ltd. - Business segments
• Exhibit 157: Samsung Electronics Co. Ltd. - Key news
• Exhibit 158: Samsung Electronics Co. Ltd. - Key offerings
• Exhibit 159: Samsung Electronics Co. Ltd. - Segment focus
• 12.16 Toyobo Co. Ltd.
• Exhibit 160: Toyobo Co. Ltd. - Overview
• Exhibit 161: Toyobo Co. Ltd. - Business segments
• Exhibit 162: Toyobo Co. Ltd. - Key offerings
• Exhibit 163: Toyobo Co. Ltd. - Segment focus
• 12.17 WuXi Biologics Cayman Inc.
• Exhibit 164: WuXi Biologics Cayman Inc. - Overview
• Exhibit 165: WuXi Biologics Cayman Inc. - Product / Service
• Exhibit 166: WuXi Biologics Cayman Inc. - Key offerings

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 167: Inclusions checklist
• Exhibit 168: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 169: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 170: Research methodology
• Exhibit 171: Validation techniques employed for market sizing
• Exhibit 172: Information sources
• 13.5 List of abbreviations
• Exhibit 173: List of abbreviations